1. Short title This Act may be cited as the Modernizing Opioid Treatment Access Act . 2. Expansion of methadone for opioid use disorder through prescribing and pharmacies Section 303(h) of the Controlled Substances Act ( 21 U.S.C. 823(h) ), is amended— (1) in paragraph (1)— (A) in the matter preceding subparagraph (A), in the first sentence, by inserting (other than narcotic drugs in schedule III, IV, or V) after drugs ; and (B) by striking subparagraph (B) and inserting the following: (B) if the Attorney General determines that the applicant will comply with standards established by the Attorney General respecting— (i) security of stocks of narcotic drugs for such treatment; and (ii) the maintenance of records (in accordance with section 307) on such drugs; and ; and (2) by striking paragraph (2) and inserting the following: (2) (A) The requirements of paragraph (1) applicable to methadone medication for opioid use disorder are waived, and the Attorney General, in consultation with the Secretary, shall separately register persons described in subparagraph (B) to prescribe methadone for opioid use disorder to be dispensed through a pharmacy for individuals for unsupervised use. (B) Persons described in this subparagraph are persons who— (i) are licensed, registered, or otherwise permitted, by the United States or the jurisdiction in which they practice, to prescribe controlled substances in the course of professional practice